-
Silver Creek Pharmaceuticals Appoints Mark Corrigan, M.D. As President
13 Feb 2024 00:56 GMT
… ;PRNewswire/ -- Silver Creek Pharmaceuticals, a clinical-stage biotechnology company … and on the Board of Avanir prior to its acquisition by … , New Products Planning
Silver Creek Pharmaceuticals
cmacgregor@silvercreekpharma.com
View original …
-
Madrigal Pharmaceuticals Appoints Bill Sibold as Chief Executive Officer
11 Sep 2023 11:00 GMT
… Chief Commercial Officer of Avanir Pharmaceuticals, President and CEO of … Madrigal story together.” About Madrigal Pharmaceuticals Madrigal Pharmaceuticals, Inc. (Nasdaq: MDGL … Contact
Alex Howarth, Madrigal Pharmaceuticals, Inc., IR@madrigalpharma.com …
-
Head to Head Survey: Concert Pharmaceuticals (NASDAQ:CNCE) versus Amylyx Pharmaceuticals (NASDAQ:AMLX)
04 Jan 2023 07:09 GMT
… more favorable than Amylyx Pharmaceuticals.
Summary
Concert Pharmaceuticals beats Amylyx Pharmaceuticals on 7 of the … . It has strategic collaborations with Avanir Pharmaceuticals, Inc.; Jazz Pharmaceuticals, Inc.; Cipla Technologies; and Processa …
-
Avanir Pharmaceuticals Joins California Life Sciences
13 Aug 2021 03:33 GMT
… ;PRNewswire/ -- Avanir Pharmaceuticals, Inc. today announced it … Avanir on Twitter and LinkedIn.
About Avanir Pharmaceuticals, Inc.
Avanir Pharmaceuticals, … Inc. is a pharmaceutical company …
-
Hudson neurologist, Ohio pharmaceutical rep plead guilty in prescription drug kickback scheme
01 Nov 2022 17:18 GMT
… doctor and a central Ohio pharmaceutical representative have pleaded guilty to … Deepak Raheja, 66, and former Avanir Pharmaceuticals sales rep Frank Mazzucco, 44 … $331,550 in payments from Avanir for speaking about Nuedexta at …
-
Analyzing Galmed Pharmaceuticals (NASDAQ:GLMD) & Concert Pharmaceuticals (NASDAQ:CNCE)
08 Oct 2022 06:02 GMT
… , but lower revenue than Concert Pharmaceuticals. Concert Pharmaceuticals is trading at a lower … . It has strategic collaborations with Avanir Pharmaceuticals, Inc.; Jazz Pharmaceuticals, Inc.; Cipla Technologies; and …
-
Amyotrophic Lateral Sclerosis Market Size was USD 490 Million in 2021, DelveInsight
19 Mar 2024 12:53 GMT
… , AB Science, Eledon Pharmaceuticals, Revalesio Corporation, Biohaven Pharmaceuticals, UCB Pharma, Ra Pharmaceuticals, and others … ;s Republic of China.
• Nuedexta (Avanir Pharmaceuticals)
Nuedexta (dextromethorphan hydrobromide/quinidine …
-
Concert Pharmaceuticals Reports 2021 Financial Results and Provides Company Update
03 Mar 2022 11:00 GMT
… Quarter of 2022. Avanir Pharmaceuticals and Otsuka Pharmaceuticals are conducting a … Tables to Follow –
Concert Pharmaceuticals, Inc.
Consolidated Statements of Operations … ,162
About Concert
Concert Pharmaceuticals is a clinical stage biopharmaceutical …
-
Concert Pharmaceuticals, Inc. (CNCE) CEO Roger Tung on Q4 2021 Results - Earnings Call Transcript
03 Mar 2022 16:11 GMT
Concert Pharmaceuticals, Inc. (NASDAQ:CNCE) Q4 … welcome to the Concert Pharmaceuticals'; Fourth Quarter 2021 … and welcome to Concert Pharmaceuticals'; fourth quarter 2021 investor … existing licensing agreement with Avanir.
We have the potential to …
-
AVP-786 Falls Short in Phase 3 Study of Alzheimer Disease Agitation
14 Feb 2024 01:43 GMT
… assessing AVP-786 (Otsuka Pharmaceutical), a CYP2D6 inhibitor, showed … disease/
2. Avanir Pharmaceuticals, Inc. Reports Phase 3 … s Dementia. news release. Avanir Pharmaceuticals; March 25, 2019. … ;news-releases/avanir-pharmaceuticals-inc-reports-phase-3 …